Skip to main content
Download PDF

Vitamin D deficiency among smear positive pulmonary tuberculosis patients and their tuberculosis negative household contacts in Northwest Ethiopia: a case–control study

Annals of Clinical Microbiology and Antimicrobials volume 16, Article number: 36 (2017) Cite this article

Abstract

Background

Vitamin D is a fat-soluble vitamin that increases the immunity against tuberculosis (TB), decreases the re-activation of latent TB and reduces the severity of active TB disease. Epidemiological studies on the prevalence of vitamin D deficiency, and its association with TB showed inconsistent results in different countries. This study was aimed to determine the prevalence of vitamin D deficiency and its association with TB in Northwest Ethiopia.

Methods

A case–control study was conducted among smear positive pulmonary tuberculosis patients and their household contacts without symptoms suggestive of TB. Study participants were recruited at 11 TB diagnostic health facilities in North and South Gondar zones of Amhara region between May 2013 and April 2015. The spot-morning-spot sputum samples and 5 ml blood sample were collected prior to commencing TB treatment for the diagnosis of TB and serum vitamin D assay, respectively. The diagnosis of TB was performed using smear microscopy and GeneXpert. Serum vitamin D level was analyzed using VIDAS 25 OH Vitamin D Total testing kits (Biomerieux, Marcy I’Etoile, France) on mini VIDAS automated immunoassay platform. Vitamin D status was interpreted as deficient (<20 ng/ml), insufficient (20–29 ng/ml), sufficient (30–100 ng/ml) and potential toxicity (>100 ng/ml).

Results

Of the total study participants, 134 (46.2%) were vitamin D deficient, and only 56 (19.3%) had sufficient vitamin D level. A total of 59 (61.5%) TB patients and 75 (38.7%) non TB controls were vitamin D deficient. Results of multivariate logistic regression analyses showed a significantly higher vitamin D deficiency among tuberculosis cases (p < 0.001), females (p = 0.002), and urban residents (p < 0.001) than their respective comparison groups. Moreover, age groups of 35–44 (p = 0.001), 45–54 (p = 0.003) and ≥55 (p = 0.001) years had significantly higher vitamin D deficiency compared with age group <15 years.

Conclusions

Vitamin D deficiency is highly prevalent among TB patients and non TB controls in Ethiopia where there is year round abundant sunshine. Study participants with tuberculosis, females, older age groups, and urban residents had significantly higher prevalence of vitamin D deficiency. These findings warrant further studies to investigate the role of vitamin D supplementation in the prevention and treatment of tuberculosis in high TB burden countries like Ethiopia.

Background

Tuberculosis (TB) remains one of the deadliest communicable diseases in the world. According to World Health Organization (WHO) global TB report 2014, Ethiopia ranked 7th among the 22 high TB burden countries and 15th among the 27 high Multi-Drug Resistant Tuberculosis (MDR-TB) burden countries in the world. Ethiopia had an estimated 211 prevalent TB case per 100,000 population and a total of 30,000 TB related deaths. Among patients with notified pulmonary TB cases in the year 2013, there was an estimated 1400 MDR-TB cases in the country [1].

Vitamin D is a fat-soluble vitamin that plays important role against infectious diseases including tuberculosis [2]. The two most likely ways by which vitamin D controls the immune system in the fight against M. tuberculosis are: (1) Vitamin D decreases the viability of M. tuberculosis by increasing the fusion of the phagosome and lysosome in infected macrophages [3]; (2) It may improve the production of LL-37, an antimicrobial peptide of the cathelicidin family [3,4,5,6]. Defensin and cathelicidin are some of the antimicrobial peptides that involve as a first line of defenses in the inhibition of infections with infectious diseases such as TB. The vitamin D in neutrophils and macrophages controls the hCAP-18 gene that codes for LL-37, hence, vitamin D may increase the host body defenses to control TB [3,4,5,6,7]. The use of vitamin D to treat TB patients has a long history even before Robert Koch discovered the etiologic agent of TB [3].

Vitamin D can be present naturally in very few foods, as dietary supplements, and produced endogenously when ultraviolet rays from sunlight strike the skin and trigger vitamin D synthesis, however, vitamin D deficiency has been shown to be common in low-income countries, including those in equatorial Africa [8,9,10].

Inadequate vitamin D level, vitamin D insufficiency or deficiency, is a global problem. It was estimated that one billion people globally have inadequate level of vitamin D [11]. Previous studies have shown that vitamin D deficiency is a problem in Africa [12,13,14,15,16]. Higher prevalence of vitamin D deficiency was observed among untreated pulmonary TB patients compared to the non-TB healthy controls [17]. Vitamin D deficiency among TB patients have been reported in different African countries with the prevalence ranging from 8.5 to 62.7% [8, 10, 14,15,16]. A study conducted in the central part of Ethiopia showed a prevalence of 42% vitamin D deficiency among school children [18]. Another study conducted in Israel among adult Ethiopian women immigrants showed that all women (five) with hypocalcaemia were also vitamin D deficient [19].

Previous reports showed that inadequate vitamin D status is a public health problem globally. However, there are discrepancies in the prevalence of vitamin D deficiency, and the association between vitamin D deficiency and TB among studies conducted in different countries. The lack of consistency of results may be due to the fact that the level of vitamin D in human is affected by several factors such as race, latitude, exposure to sunlight, socioeconomic status, nutrition, and traditional/cultural traits [20]. As far as our knowledge is concerned, there are quite few reports, one on the prevalence of vitamin D deficiency among children and the other on Ethiopian women immigrants, but no data on the association between vitamin D deficiency and tuberculosis in Ethiopia. Therefore, this study was aimed to determine the prevalence of vitamin D deficiency and the association between vitamin D deficiency and tuberculosis among smear positive pulmonary tuberculosis patients and their household contacts without symptoms suggestive of TB in Northwest Ethiopia.

Methods

Study design, settings and study period

A prospective case–control study was conducted among smear positive pulmonary tuberculosis patients and their household contacts without symptoms suggestive of TB (controls). A total of 290 study participants were included in this study. Of them, 96 participants are TB patients and 194 are non TB controls. Study participants were recruited at 11 TB diagnostic health facilities in North and South Gondar zones of Amhara region between May 2013 and April 2015. The 11 TB diagnostic health facilities included in this study are Gondar Health Center (HC), Marakie HC, Woleka HC, Gebriel HC, Azezo HC, Kola Duba HC, Tseda HC, Maksegnit HC, Enferanze HC, Addis Zemen HC, and Woreta HC.

Based on the 2007 census conducted by the central statistical agency of Ethiopia (CSA) [21], Amhara region has a total population of 17,221,976, of whom, 8,641,580 are males and 8,580,396 are females. It is the second populous region in the country. The Amhara region extends from 9° to 13° 45′ N and 36° to 40° 30′ E. It covers approximately 161,828.4 sq km in area. This is 11% of Ethiopia’s total area. This land consists of three major geographical zones. These are highlands (above 2300 m above sea level), semi-highlands (1500–2300 m above sea level) and lowlands (below 1500 m above sea level) accounting 20, 44 and 28%, respectively. The Amhara region, like the rest of the country, is located within the tropics where there is no significant variation in day length and the angle of the sun throughout the year. As a result, the average annual temperatures in the region are high. The region has three climatic zones such as hot dry tropical (800–1830 m above sea level), sub tropical (1830–2440 m above sea level), cool temperature (over 2440 m above sea level) with average annual temperatures 27, 22 and 16 °C, respectively. In all climatic zones there is sunshine throughout the year.

Recruitment of the study participants

All smear positive TB patients diagnosed during the study period and their household contacts without symptoms suggestive of TB, volunteered to participate were enrolled in this study. Clinical screening of contacts was conducted using the WHO screening criteria [22] in 2 weeks time after the index case diagnosed. For all study subjects, information on the socio-demographic data was collected using structured questionnaire. The spot-morning-spot sputum samples and 5 ml venous blood sample were collected prior to commencing TB treatment. Sputum and serum specimens were stored at −20 °C until transported to University of Gondar and Felege Hiwot hospitals using cold box. Sputum samples transported to University of Gondar Hospital for GeneXpert testing while serum samples transported to Felege Hiwot Hospital, Bahir Dar for serum Vitamin D assay.

Laboratory diagnosis of tuberculosis

The spot- morning-spot sputum samples collected from presumptive TB patients were examined using either Zihel Neelsen microscopy or light emitting diode (LED) fluorescence microscopy (FM) for acid fast bacilli (AFB) at respective health facilities following the manufacturer’s procedures (Zeiss, Germany). Split sputum samples of all smear positive TB patients were further examined using the Gene Xpert MTB/RIF (Cepheid, USA) following the standard procedure to confirm TB positive study participants.

Study participants were considered TB positive, if their sputum samples are positive for TB by GeneXpert or both GeneXpert and smear microscopy. Study subjects were considered TB negative controls, if household contacts of smear positive TB cases had no symptoms suggestive of TB. TB negative study participants were included in this study as a control to compare the association between TB and vitamin D deficiency.

Measurement of serum vitamin D concentration

Serum samples were separated by centrifugation and frozen immediately at −20 °C. Serum 25 OH Vitamin D levels were measured using a VIDAS 25 OH Vitamin D Total testing kits (Biomerieux, Marcy I’Etoile, France) on mini VIDAS automated immunoassay platform. VIDAS 25 OH Vitamin D Total is a quantitative test using Enzyme Linked Fluorescent Assay (ELFA) technology. The vitamin D status of study participants was interpreted based on the serum 25-(OH) Vitamin D concentration following the manufacturer’s instructions as deficient (<20 ng/ml), insufficient (20–29 ng/ml), sufficient (30–100 ng/ml) and potential toxicity (>100 ng/ml). The VIDAS 25-OH Vitamin D Total assay showed excellent performance with correlation of r = 0.93 compared with the reference standard liquid chromatography/mass spectrometry methods (LC–MS/MS) [23].

Quality control of laboratory methods

The reliability of the study findings was guaranteed by implementing quality control measures throughout the whole process of the laboratory work. All materials, equipment and procedures were adequately controlled.

Statistical analysis

The data analysis was made using SPSS version 16 software (SPSS Inc., Chicago, IL) after the data was entered and properly cleared. The Chi square test was used to compare the categorical variables. The two important outcome variables assessed using logistic regression analysis model were TB and Vitamin D deficiency. The odds ratios (OR) and 95% confidence intervals (CI) were calculated for demographic and epidemiologic variables by using logistic regression analysis. A multivariate binary logistic regression analysis was used to identify independent risk factors associated with TB and vitamin D deficiency in the study participants. P value <0.05 was considered statistically significant.

Results

General characteristics of study participants

A total of 290 study participants (141 males and 149 females) were included in this study. The study included 96 TB patients (57 males and 39 females) and 194 non TB controls (84 males and 110 females). Majority, 180 (62.1%) of the study participants were urban residents. Eighty one of the study participants (27.9%) were children, <15 years of age. The proportion of children among controls was 35.1% compared to the 13.5% children among TB cases. The mean age (SD) of the study subjects was 27.1 (16.7) years (Table 1).

Table 1 Socio-demographic and clinical characteristics of study participants (N = 290)
Full size table

Serum vitamin D levels

Of the total study participants, 134 (46.2%) were vitamin D deficient, 100 (34.5%) had insufficient vitamin D and only 56 (19.3%) study participants had sufficient vitamin D level. In the TB positive cases, 59 patients (61.5%) were vitamin D deficient and 20 (20.8%) had insufficient vitamin D. While, 75 study participants (38.7%) in the non TB controls were vitamin D deficient and 80 (41.2%) had insufficient vitamin D (Table 2).

Table 2 Vitamin D levels among study participants (n = 290)
Full size table

Risk factors associated with tuberculosis

As shown in Table 3, tuberculosis cases had significantly higher rate of vitamin D deficiency (AOR 3.3; 95% CI 1.8–6.0; p < 0.001) than non TB controls. Significantly higher number of males had active TB compared with females (AOR 2.5; 95% CI 1.4–4.3; p = 0.001). Furthermore, study participants in the age groups of 15–24 (AOR 4.5; 95% CI 2.0–10.2; p < 0.001) and 25–34 (AOR 4.3; 95% CI 1.9–96; p < 0.001) years had significantly higher proportion of active TB compared with age group <15 years of age.

Table 3 Risk factors associated with tuberculosis (n = 290)
Full size table

Risk factors associated with vitamin D deficiency

Results of multivariate logistic regression analyses showed that females had significantly higher prevalence of vitamin D deficiency than males (AOR 2.3; 95% CI 1.3–3.9; p = 0.002). Urban residents had significantly higher proportion of vitamin D deficiency compared with rural residents (AOR 3.0; 95% CI 1.7–5.3; p < 0.001). Moreover, study subjects in the age groups of 35–44 (AOR 4.5; 95% CI p = 0.001), 45–54 (AOR 5.8; 95% CI 0 1.8–18.6; p = 0.003) and ≥55 (AOR 7.5; 95% CI 2.3–24.2; p = 0.001) years had significantly higher proportion of vitamin D deficiency compared with age group <15 years of age (Table 4).

Table 4 Risk factors associated with vitamin D deficiency (n = 290)
Full size table

Discussion

In this study, a high prevalence of vitamin D deficiency, 46.2% was observed among the total study participants. This finding is in agreement with a previous report from the central part of Ethiopia with the total prevalence of 42% vitamin D deficiency among school children [18]. This finding shows that vitamin D deficiency is highly prevalent among the general community in Ethiopia.

The prevalence of vitamin D deficiency among TB patients (61.5%) reported in our study is comparable to that reported in South Africa (62.7%) [16]. On the contrary, lower prevalence of vitamin D deficiency was reported in Tanzania (10.6%) [8], Guinea Bissau (8.5%) [10] and Uganda (7%) [14] compared to our study. These discrepancies among different reports might be due to the differences in the laboratory assay methods used to measure vitamin D level, definition of vitamin D deficiency, dietary habits of the study population, latitude of the study sites and frequencies of co-morbidities in the study population of different studies. The different techniques used to measure serum vitamin D concentrations in the studies done in Uganda [14], Guinea Bissau [10] and Tanzania [8] were a semi-automated solid phase extraction reverse phase high performance liquid chromatography assay, isotope-dilution liquid chromatography–tandem mass spectrometry on an API3000 mass spectrometer and Radio Immuno Assay (RIA) with 125I-labeled 25(OH) D [125I-25(OH)D] as tracer using a kit from Immunodiagnostic-Systems, respectively.

In this study, multivariate logistic regression analysis showed a significant association between vitamin D deficiency and tuberculosis (p < 0.001). The possible association between vitamin D deficiency and active tuberculosis was first reported more than 20 years ago [24], however, several studies reported conflicting results. Similar to our study, many studies have reported a significant association between vitamin D deficiency and TB. Studies in West Africa [10], Australia [12], Kenya [17], Vietnam [25], Tanzania [26] and India [27] have reported higher levels of vitamin D deficiency in patients with TB compared with non TB controls. A meta-analysis by Nnoaham et al. also showed that serum vitamin D levels were 0.68 standard deviation lower in TB patients compared to controls [20]. However, studies from Indonesia [28], China [29], Hong Kong [30] and Korea [31] have reported no significant difference in serum vitamin D levels between TB patients and controls. The discrepancies between these studies may be due to differences in cultural characteristics, ethnic, sunlight exposure, skin color or dietary practices. Although there is good evidence to suggest that a decrease in serum vitamin D levels compromises immunity and leads to the re-activation of latent tuberculosis [32], the low serum vitamin D levels may also result from tuberculosis itself.

In the present study, it was noted that a significantly higher level of vitamin D deficiency was observed among females compared with males (p = 0.002). Similarly, a report from Pakistan showed that vitamin D deficiency was significantly higher in females than males [33]. Possible reasons for this female preponderance might be due to poorer nutritional status than their male counterparts, inadequate exposure to sunlight because of the culture of most females to stay at home, and pregnancy experiences.

Increasing age was found to be significantly associated with vitamin D deficiency in our study. Similar findings have also been observed in reports from Uganda [34], and in the USA [35]. Older people are prone to develop vitamin D deficiency because of various risk factors: decreased dietary intake, diminished sunlight exposure, reduced skin thickness, impaired intestinal absorption, and impaired hydroxylation in the liver and kidneys [36–38,37,].

In this study, urban residence was found to be a significant risk factor for vitamin D deficiency compared with rural residence. Our finding was in agreement with the findings of the previous studies in the central part of Ethiopia [18] and in Peru [39] that showed significant association between vitamin D deficiency and urban environment. This might be due to lifestyle changes associated with urbanization that may lead to less time spent outdoors which in turn can be associated with being vitamin D deficient.

The major limitations of our study include dietary intake, biochemical variables (calcium, parathyroid hormone), HIV status and latent TB infections, all of which could affect vitamin D deficiency, were not considered in this study. However, the effect of these factors on the level of vitamin D among TB patients was controlled using tight control groups from the same household who did not have TB diseases. As the cases and controls shared similar environment and household, the cases and controls are likely to have similar risk factors exposures including dietary intake.

Conclusions

Vitamin D deficiency is highly prevalent among TB patients and non TB controls in Ethiopia where there is year round abundant sunshine. This study confirms a significant association between vitamin D deficiency and tuberculosis in Ethiopia. Vitamin D deficiency was also significantly higher in females, older age groups, and urban residents. The findings of this study warrant further studies first to resolve the chicken–egg dilemma of the association between vitamin D deficiency and TB using cohort study and then to determine whether vitamin D supplementation can have a role in the prevention and treatment of tuberculosis in high TB burden countries like Ethiopia.

References

  1. World Health Organization. Global tuberculosis report. Geneva: WHO; 2014.

    Google Scholar 

  2. Hewison M. Vitamin D and the immune system: new perspectives on an old theme. Endocrinol Metab Clin North Am. 2010;39:365–79.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Chocano-Bedoya P, Ronnenberg AG. Vitamin D and tuberculosis. Nutr Rev. 2009;67:289–93.

    Article  PubMed  Google Scholar 

  4. Martineau AR, Wilkinson KA, Newton SM, Floto RA, Norman AW, et al. IFN-gamma- and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37. J Immunol. 2007;178:7190–8.

    Article  CAS  PubMed  Google Scholar 

  5. Ralph AP, Kelly PM, Anstey NM. L-arginine and vitamin D: novel adjunctive immunotherapies in tuberculosis. Trends Microbiol. 2008;16:336–44.

    Article  CAS  PubMed  Google Scholar 

  6. Campbell GR, Spector SA. Vitamin D inhibits human immunodeficiency virus type 1 and Mycobacterium tuberculosis infection in macrophages through the induction of autophagy. PLoS Pathog. 2012;8:1523–5.

    CAS  Google Scholar 

  7. Liu PT, Stenger S, Li H, Wenzel L, Tan BH. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006;311:1770–3.

    Article  CAS  PubMed  Google Scholar 

  8. Friis H, Range N, Pedersen ML, Mølgaard C, Changalucha J, et al. Hypovitaminosis D is common among pulmonary tuberculosis patients in Tanzania but is not explained by the acute phase response. J Nutr. 2008;138:2474–80.

    Article  CAS  PubMed  Google Scholar 

  9. Fischer PR, Thacher TD, Pettifor JM. Pediatric vitamin D and calcium nutrition in developing countries. Rev Endocr Metab Disord. 2008;9:181–92.

    Article  CAS  PubMed  Google Scholar 

  10. Wejse C, Olesen R, Rabna P, Kaestel P, Gustafson P, et al. Serum 25- hydroxyvitamin D in a West African population of tuberculosis patients and unmatched healthy controls. Am J Clin Nutr. 2007;86:1376–83.

    CAS  PubMed  Google Scholar 

  11. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266–81.

    Article  CAS  PubMed  Google Scholar 

  12. Gibney K, MacGregor L, Leder K, et al. Vitamin D deficiency is associated with tuberculosis and latent tuberculosis infection in immigrants from sub-Saharan Africa. Clin Infect Dis. 2008;46:443–6.

    Article  CAS  PubMed  Google Scholar 

  13. van der Meer M, Middelkoop B, Boeke A, Lips P. Prevalence of vitamin D deficiency among Turkish, Moroccan, Indian and sub-Sahara African populations in Europe and their countries of origin: an overview. Osteoporos Int. 2011;22:1009–21.

    Article  CAS  PubMed  Google Scholar 

  14. Nansera D, Graziano F, Friedman D, et al. Vitamin D and calcium levels in Ugandan adults with human immunodeficiency virus and tuberculosis. Int J Tuberc Lung Dis. 2011;15:1522–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Banda R, Mhemedi B, Allain T. Prevalence of vitamin D deficiency in adult tuberculosis patients at a central hospital in Malawi. Int J Tuberc Lung Dis. 2011;15:408–10.

    CAS  PubMed  Google Scholar 

  16. Martineau A, Nhamoyebonded S, Onic T, et al. Reciprocal seasonal variation in vitamin D status and tuberculosis notifications in Cape Town, South Africa. Proc Natl Acad Sci. 2011;108:19013–7.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Davies P, Church H, Brown R, et al. Raised serum calcium in tuberculosis patients in Africa. Eur J Respir Dis. 1987;71:341–4.

    CAS  PubMed  Google Scholar 

  18. Wakayo T, Belachew T, Vatanparast H, Whiting SJ. Vitamin D deficiency and its predictors in a country with thirteen months of sunshine: the case of school children in central Ethiopia. PLoS ONE. 2015;10(3):e0120963. doi:10.1371/journal.pone.0120963.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Fogelman Y, Rakover Y, Luboshitzky R. High prevalence of vitamin D deficiency among Ethiopian women immigrants to Israel: exacerbation during pregnancy and lactation. Isr J Med Sci. 1995;31(4):221–4.

    CAS  PubMed  Google Scholar 

  20. Nnoaham KE, Clarke A. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol. 2008;37:113–9.

    Article  PubMed  Google Scholar 

  21. Central Statistical Agency (CSA) of Ethiopia. Summary and statistical report of the 2007 population and housing census. Addis Ababa: CSA; 2008.

    Google Scholar 

  22. World Health Organization. Global Tuberculosis Control 2010. WHO/HTM/TB/2010.7. Geneva: WHO; 2010.

    Google Scholar 

  23. Moreau E, Bacher S, Mery S, Le Goff C, Piga N, Vogeser M, Hausmann M, Cavalier E. Performance characteristics of the VIDAS® 25-OH Vitamin D Total assay—comparison with four immunoassays and two liquid chromatography-tandem mass spectrometry methods in a multicentric study. Clin Chem Lab Med. 2015. doi:10.1515/cclm-2014-1249.

    Google Scholar 

  24. Bartley J. Vitamin D: emerging roles in infection and immunity. Expert Rev Anti Infect Ther. 2010;8:1359–69.

    Article  CAS  PubMed  Google Scholar 

  25. Ho-Pham LT, Nguyen ND, Nguyen TT, et al. Association between vitamin D insufficiency and tuberculosis in a Vietnamese population. BMC Infect Dis. 2010;10:306.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Tostmann A, Wielders JPM, Kibiki GS, Verhoef H, Boeree MJ. Serum 25-hydroxy-vitamin D3 concentrations increase during tuberculosis treatment in Tanzania. Int J Tuberc Lung Dis. 2010;14:1147–52.

    CAS  PubMed  Google Scholar 

  27. Wilkinson RJ, Llewelyn M, Toossi Z, et al. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in West London: a casecontrol study. Lancet. 2000;355:618–21.

    Article  CAS  PubMed  Google Scholar 

  28. Grange JM, Davies PD, Brown RC, Woodhead JS, Kardjito T. A study of vitamin D levels in Indonesian patients with untreated pulmonary tuberculosis. Tubercle. 1985;66:187–91.

    Article  CAS  PubMed  Google Scholar 

  29. Chan TY, Poon P, Pang J, et al. A study of calcium and vitamin D metabolism in Chinese patients with pulmonary tuberculosis. J Trop Med Hyg. 1994;97:26–30.

    CAS  PubMed  Google Scholar 

  30. Chan TY. Differences in vitamin D status and calcium intake: possible explanations for the regional variations in the prevalence of hypercalcemia in tuberculosis. Calcif Tissue Int. 1997;60:91–3.

    Article  CAS  PubMed  Google Scholar 

  31. Koo HK, Lee JS, Jeong YJ, et al. Vitamin D deficiency and changes in serum vitamin D levels with treatment among tuberculosis patients in South Korea. Respirology. 2012;17:808–13.

    Article  PubMed  Google Scholar 

  32. Rook GAW. The role of vitamin D in tuberculosis. Am Rev Respir Dis. 1988;138:768–70.

    Article  CAS  PubMed  Google Scholar 

  33. Raheel I, Sultan MK, Adnan Q, Ehtesham H, Hassan BU. Vitamin D deficiency in patients with tuberculosis. J Coll Phys Surg Pak. 2013;23:780–3.

    Google Scholar 

  34. Davis K, Edrisa M, Richard S, William W, Harriet MK. Vitamin D deficiency among adult patients with tuberculosis: a cross sectional study from a national referral hospital in Uganda. BMC Res Notes. 2013; 6:293. http://www.biomedcentral.com/1756-0500/6/293.

  35. Gloth FM, Gundberg CM, Hollis BW, Haddad JG, Tobin JD. Vitamin D deficiency in homebound elderly persons. JAMA. 1995;274:1683–6.

    Article  PubMed  Google Scholar 

  36. Omdahl JL, Garry PJ, Hunsaker LA, Hunt WC, Goodwin JS. Nutritional status in a healthy elderly population: vitamin D. Am J Clin Nutr. 1982;36:1225–33.

    CAS  PubMed  Google Scholar 

  37. McKenna MJ. Differences in vitamin D status between countries in young adults and the elderly. Am J Med. 1992;93:69–77.

    Article  CAS  PubMed  Google Scholar 

  38. Holick MF. Environmental factors that influence the cutaneous production of vitamin D. Am J Clin Nutr. 1995;61:638S–45S.

    CAS  PubMed  Google Scholar 

  39. Checkley W, Robinson CL, Baumann LM, et al. 25-hydroxy vitamin D levels are associated with childhood asthma in a population-based study in Peru. Clin Exp Allergy. 2015;45:273–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Authors’ contributions

BT conceived the study, involved in proposal writing and design, data collection, analysis, interpretation and draft manuscript writing. FM, BG and MM involved in proposal writing and design and reviewed the manuscript. DH, NH and SY involved in data analysis, interpretation of results and reviewed the manuscript. KM, YK and PGS reviewed the manuscript. All authors read and approved the final manuscript.

Acknowledgements

The authors would like to thank data collectors and study participants from all study areas in Northwest Ethiopia. Authors also express their appreciation to Fikerte Estefanus and Workeneh Ayalew for their kind assistance during serum vitamin D level measurement at Felege Hiwot Hospital Laboratory, and Asnakew Belete and Kefyalew Negerie for their assistance during TB diagnosis using GeneXpert assay at University of Gondar. Authors would also like to acknowledge Degu Jerene for his contribution to review the manuscript.

Competing interests

The authors declare that they have no competing interests.

Availability of data and materials

The authors declare that the data supporting the findings of this study are available within the article.

Consent for publication

All authors read and approved the final manuscript for submission for publication.

Ethics approval and consent to participate

The ethical approval of the study was obtained from institutional ethical review board of University of Gondar, Ethiopia. Written informed consent was obtained from all eligible study participants or from parents/legal guardians of any participants under 18 years of age. Moreover, oral consent was also obtained from under 18 years of age study participants. Tuberculosis positive study participants received the standard anti-TB treatment regimens based on the national treatment guideline without delay. Information obtained in each course of the study was kept confidential.

Funding

The United States Agency for International Development (USAID) supported this work through HEAL TB, under cooperative agreement number AID-663-A-11-00011. The contents of the article are the responsibility of the authors alone and do not necessarily reflect the views of USAID or the United States government.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Author information

Authors and Affiliations

  1. Department of Medical Microbiology, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia

    Belay Tessema & Feleke Moges

  2. Management Sciences for Health, Help Ethiopia Address the Low Performance of Tuberculosis (HEAL TB) Project, Addis Ababa, Ethiopia

    Dereje Habte, Nebiyu Hiruy, Kassahun Melkieneh & Muluken Melese

  3. Department of Chemistry, College of Natural and Computational Sciences, University of Gondar, Gondar, Ethiopia

    Shewaye Yismaw

  4. USAID/Ethiopia, Addis Ababa, Ethiopia

    Yewulsew Kassie

  5. Monitoring and Evaluation TA, National Tuberculosis Program, Lilongwe, Malawi

    Belaineh Girma

  6. Management Sciences for Health, Health Programs Group, Arlington, VA, USA

    Pedro G. Suarez

Authors
  1. Belay Tessema
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Feleke Moges
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dereje Habte
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nebiyu Hiruy
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shewaye Yismaw
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kassahun Melkieneh
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yewulsew Kassie
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Belaineh Girma
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Muluken Melese
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Pedro G. Suarez
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Belay Tessema.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tessema, B., Moges, F., Habte, D. et al. Vitamin D deficiency among smear positive pulmonary tuberculosis patients and their tuberculosis negative household contacts in Northwest Ethiopia: a case–control study. Ann Clin Microbiol Antimicrob 16, 36 (2017). https://doi.org/10.1186/s12941-017-0211-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12941-017-0211-3

Keywords

Annals of Clinical Microbiology and Antimicrobials

ISSN: 1476-0711

Contact us